ENVALITH
株式会社ウェルディッシュ logo

Wel-Dish.Incorporated

2901Standard MarketFoods

株式会社ウェルディッシュ logo
Wel-Dish.Incorporated2901

Wellness Business

The group's core segment, offering food, beverage, and medical/nursing care-related services

PeriodCurrentPreviousChange
Net sales (H1 FY2026 ending August 2026)¥1,554 million¥1,112 million (FY2025 ending August 2025, irregular 5-month period)
Segment profit (H1 FY2026 ending August 2026)¥114 million¥75 million (FY2025 ending August 2025, irregular 5-month period)
Segment profit margin (H1 FY2026 ending August 2026)7.3%6.7% (FY2025 ending August 2025, irregular 5-month period)
Goodwill balance (end of February 2026)¥3,971 million¥2,148 million (end of August 2025)

Business Details

Based on mineral technology dating back to the company's founding, this segment operates domestic food sales, food supply services for medical and nursing care institutions, water server services, and export sales to China. The absorption merger of GrandRoof Co., Ltd. (September 2025) and the transformation of IMG Holdings Co., Ltd. (now Mirife) into a wholly owned subsidiary (December 2025) have incorporated medical and welfare consulting functions. This is the group's core segment, accounting for approximately 94.7% of consolidated net sales.

Recent Overview

Scale expansion through aggressive M&A; goodwill increased significantly following consolidation of IMG Holdings

For H1 FY2026 (ending August 2026), net sales were ¥1,554 million and segment profit was ¥114 million. Strong corporate sales of bottled beverages and a significant increase in the number of corporate water server customers contributed to the results. Following the share exchange that made IMG Holdings Co., Ltd. (now Mirife) a wholly owned subsidiary (effective December 11, 2025), goodwill of ¥1,945 million (provisional figure) arose within the Wellness Business. As a subsequent event, ACA Next Co., Ltd. became a consolidated subsidiary effective March 2, 2026 (acquisition cost of ¥969 million), bringing in contracted meal services, nursing care facility operations, and a ready-to-eat food factory.

Key Products

product
Food and beverage sales (corporate customers)

Corporate sales of bottled beverages continued to perform well. Sales of non-bottled beverages remained flat. Wholesale orders from China increased significantly, and capital investment is underway to expand capacity. Ishigaki Foods Co., Ltd. (established via new incorporation-type company split in February 2026) handles food and beverage sales to consumers (B2C).

service
Food supply services for medical and nursing care institutions

The company provides food supply services to medical and nursing care institutions, with a growing customer base. Manufacturing and distribution networks are being strengthened through collaboration with ACA Next Co., Ltd. (to become a consolidated subsidiary in March 2026 as a subsequent event), which operates contracted meal services and owns a large-scale ready-to-eat food factory.

service
Water server service

The number of corporate customers grew significantly during the interim period. The service base has been expanded by incorporating the delivered water sales business acquired from Karada Note Co., Ltd. (March 2025).

service
Medical and welfare consulting (Mirife)

IMG Holdings Co., Ltd. (renamed Mirife Co., Ltd. as of March 1, 2026) became a wholly owned subsidiary effective December 11, 2025. It provides management and business restructuring consulting for medical and welfare facilities, aiming for synergies with the company's food services. Note that for the interim period, only the balance sheet as of the deemed acquisition date (January 31, 2026) is consolidated, with contribution to earnings expected from the third quarter onward.

platform
Frozen food subscription delivery service "Dish" (for consumers)

System construction is scheduled to be completed by the end of 2025, with service launch planned within FY2026 (ending August 2026), a key priority in the medium-term management plan. Service infrastructure is being built through collaboration with ACA Next's manufacturing and distribution network.

Growth Drivers

  • Expansion of the corporate customer base for food supply services to medical and nursing care institutions (growth in both water server and food services)
  • Significant increase in wholesale orders from China and expanded production capacity through capital investment
  • Incorporation of medical and welfare consulting functions through the wholly owned subsidiary conversion of IMG Holdings Co., Ltd. (Mirife), creating synergies with food services
  • Business expansion in both B2B and B2C through consolidation of ACA Next Co., Ltd. (which operates contracted meal services, nursing care facility operations, and owns a ready-to-eat food factory)
  • Strengthening of the B2C food and beverage sales business and brand through the independent establishment of Ishigaki Foods Co., Ltd. via company split
  • Launch of the frozen food subscription delivery service "Dish" for consumers within FY2026 (ending August 2026)

Risks

  • Goodwill balance stood at ¥3,971 million (end of February 2026), accounting for approximately 51% of total assets, presenting a high level of impairment risk. The ¥1,945 million attributable to IMG Holdings is a provisional figure pending finalization of purchase price allocation (PPA), and additional intangible asset recognition or goodwill adjustment may occur once finalized
  • A large contingent liability exists in the form of debt guarantees via IMG Holdings Co., Ltd. (Mirife), totaling ¥12,652 million as of end-February 2026 (declining to ¥7,254 million as of April 14, 2026)
  • The final values of goodwill and assets/liabilities related to the acquisition of ACA Next Co., Ltd. (acquisition cost of ¥969 million) have not yet been determined, and future accounting treatment may affect earnings
  • Increased one-time expenses (due diligence, audit, and consulting fees) associated with aggressive M&A activity are pressuring operating profit (over ¥13 million in one-time expenses incurred in the interim period)
  • Delays in capital investment aimed at expanding sales to China risk resulting in lost sales opportunities
  • Operating cash flow was a significant negative ¥953 million (mainly due to an increase in advance payments of ¥998 million), making working capital management a challenge

Last updated: November 28, 2025